Follow The Filings

CRDF Cardiff Oncology Inc.

Health Care, filed as CARDIFF ONCOLOGY INC (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by CRDF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CRDF insider trades
  • $1.1M bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Gary W Pace Director
    Buy
    $1M 687,285 shares at $1.46 +51% to stake
    Traded Jul 14 Filed Jul 16
    ↗
  2. Mani Mohindru CEO
    Buy
    $50K 34,364 shares at $1.46 +139% to stake
    Traded Jul 14 Filed Jul 16
    ↗
  3. Mani Mohindru CEO
    Buy
    $30K 24,703 shares at $1.21 New stake
    Traded Jun 18 Filed Jun 22
    ↗
  4. Gary W Pace Director
    Buy
    $37K 30,000 shares at $1.22 +2.3% to stake
    Traded Jun 18 Filed Jun 22
    ↗

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
8-K 5.02,5.03,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 7.01 Filing Doc
8-K 1.01 Filing Doc
8-K 8.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
8-K 1.01,5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $488,000 $683,000 $593,000
Net income -$41.44M -$45.43M -$45.85M
Net margin * -8492.0% -6651.7% -7732.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $77.41M $95.05M $60.13M
Total non-current assets * $4.22M $2.14M $1.76M
Total assets $81.64M $97.19M $61.88M
Total current liabilities $10.44M $13.43M $16.39M
Total non-current liabilities * $1.46M $0.813M $0.102M
Total equity $69.74M $82.95M $45.39M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$30.89M -$37.69M -$37.92M
Cash from investing $36.2M $13.73M $1.34M
Cash from financing $0M $53.78M $2.58M
Net change in cash $5.31M $29.82M -$34M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.